Cargando…
Digital Therapeutics in Migraine Management: A Novel Treatment Option in the COVID-19 Era
Migraine is a chronic and often lifelong disease that directly affects over one billion people globally. Because access to migraine medical services is limited, only a minority of migraine patients are treated adequately. This situation worsened during the COVID-19 pandemic. Digital therapeutics (DT...
Autores principales: | Chen, Xingchen, Luo, Yujia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9842514/ https://www.ncbi.nlm.nih.gov/pubmed/36660558 http://dx.doi.org/10.2147/JPR.S387548 |
Ejemplares similares
-
Emerging therapeutic options for acute migraine: focus on the potential of lasmiditan
por: Rizzoli, Paul B
Publicado: (2014) -
Novel Therapeutic Targets for Migraine
por: Nisar, Areeba, et al.
Publicado: (2023) -
The epidemiology and therapeutic options for the COVID-19
por: Li, Jingwei, et al.
Publicado: (2020) -
Toward a New Era in the Management of Hepatocellular Carcinoma: Novel Perspectives on Therapeutic Options and Biomarkers
por: Gabbia, Daniela, et al.
Publicado: (2023) -
Current Treatment Options in Vestibular Migraine
por: Obermann, Mark, et al.
Publicado: (2014)